EVALUATION OF HIGH-PROTEIN SUPPLEMENTATION IN WEIGHT-STABLE HIV-POSITIVE
体重稳定的 HIV 阳性患者的高蛋白补充评估
基本信息
- 批准号:8168764
- 负责人:
- 金额:$ 1.23万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-03-10 至 2010-12-31
- 项目状态:已结题
- 来源:
- 关键词:Body Weight decreasedCD4 Positive T LymphocytesCellsComputer Retrieval of Information on Scientific Projects DatabaseControl GroupsDietary intakeEatingEnergy IntakeEvaluationFastingFundingGrantHIVInstitutionIntakePatientsProteinsRNARandomizedResearchResearch PersonnelResourcesRiskSourceSupplementationTissuesTriglyceridesUnited States National Institutes of HealthWaist-Hip RatioWeightWhey Proteingastrointestinal symptomimprovedwasting
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
HIV patients with wasting are at increased risk of opportunistic complications and fatality. We hypothesized that augmenting dietary intake with high-biologic-value protein would enhance weight and lean tissue in weight-stable subjects with a prior unintentional weight loss of >3%. Fifty-nine subjects with HIV RNA concentrations <5000 copies/mL were randomly assigned to receive a 280-kcal supplement containing 40 g whey protein or a matched isocaloric control supplement without added protein twice daily for 12 wk. Before the study, intake of total energy and protein exceeded estimated requirements (44.3 ¿ 12.6 kcal/kg/d and 1.69 ¿ 0.55 g/kg/d, respectively). Both supplements failed to increase total energy intake because of decreases in self-selected food intake. Changes in weight (0.8 ¿ 2.4 and 0.7 ¿ 2.4 kg) and lean body mass (0.3 ¿ 1.4 and 0.3 ¿ 1.5 kg) did not differ significantly between the whey protein and control groups, respectively. Waist-to-hip ratio improved more with whey protein (-0.02 ¿ 0.05) than in control (0.01 ¿ 0.03; P=0.025) at week 6 but not at week 12. Fasting triacylglycerol increased by 39 ¿ 98 mg/dL with the control supplement and decreased by 16 ¿ 62 mg/dL with whey protein at week 12 (P=0.03). CD4 lymphocytes increased by 31 ¿ 84 cells/mm3 with whey protein and decreased by 5 ¿ 124 cells/mm3 with the control supplement at 12 wk (P=0.03). Gastrointestinal symptoms occurred more often with whey protein.
该副本是使用众多研究子项目之一
由NIH/NCRR资助的中心赠款提供的资源。子弹和
调查员(PI)可能已经从其他NIH来源获得了主要资金,
因此可以在其他清晰的条目中代表。列出的机构是
对于中心,这是调查员的机构。
浪费的艾滋病毒患者有机会性并发症和死亡的风险增加。我们假设使用高生物学价蛋白增强饮食摄入量将增强体重稳定受试者的体重和瘦肉组织,而先前的无意体重损失> 3%。将<5000份/mL的HIV RNA浓度的59名受试者随机分配,以接收含有40 G乳清蛋白或匹配的等量平衡对照补充剂的280千吨补充剂,而无需每天两次添加蛋白质,为12 wk。在研究之前,总能量和蛋白质的摄入量超过估计要求(44.3€12.6 kcal/kg/d和1.69€0.55 g/kg/d)。由于自选择的食物摄入量的下降,两种补充剂都无法增加总能量摄入。体重(0.8€2.4和0.7€2.4 kg)和瘦体重(0.3€1.4和0.3€1.5€1.5 kg)的变化分别在乳清蛋白和对照组之间没有显着。乳清蛋白的腰围比(-0.02€0.05)的进步要高于第6周的对照(0.01€0.03; 0.03; p = 0.025),但在第12周时没有。空腹三酰基甘油含量增加了39�98mg/dl,与对照补充补充补充补充剂,并减少了16 62 mg/dl week week week week week perein per = 0.0 30(p)。 CD4淋巴细胞用乳清蛋白增加了84个细胞/mm3,并在12 WK时用对照补充剂改进了5»124个细胞/mm3(p = 0.03)。乳清蛋白的胃肠道症状更常见。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
FRED R SATTLER其他文献
FRED R SATTLER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('FRED R SATTLER', 18)}}的其他基金
DURABILITY OF THE EFFECTS OF TESTOSTERONE AND GROWTH HORMONE SUPPLEMENTATION
睾酮和生长激素补充剂效果的持久性
- 批准号:
8361472 - 财政年份:2011
- 资助金额:
$ 1.23万 - 项目类别:
TESTOSTERONE THRESHOLD LEVELS AND LEAN TISSUE MASS TARGETS NEEDED
所需的睾酮阈值水平和瘦肉组织质量目标
- 批准号:
8361473 - 财政年份:2011
- 资助金额:
$ 1.23万 - 项目类别:
TESTOSTERONE AND GROWTH HORMONE IMPROVE BODY COMPOSITION AND
睾酮和生长激素改善身体成分
- 批准号:
8361388 - 财政年份:2011
- 资助金额:
$ 1.23万 - 项目类别:
WHOLE BODY AND MUSCLE PROTEIN METABOLISM ARE NOT AFFECTED BY ACUTE DEVIATIONS
全身和肌肉蛋白质代谢不受急性偏差的影响
- 批准号:
8361467 - 财政年份:2011
- 资助金额:
$ 1.23万 - 项目类别:
TESTOSTERONE AND GROWTH HORMONE IMPROVE BODY COMPOSITION AND
睾酮和生长激素改善身体成分
- 批准号:
8168784 - 财政年份:2010
- 资助金额:
$ 1.23万 - 项目类别:
EVALUATION OF HIGH-PROTEIN SUPPLEMENTATION IN WEIGHT-STABLE HIV-POSITIVE
体重稳定的 HIV 阳性患者的高蛋白补充评估
- 批准号:
7954017 - 财政年份:2009
- 资助金额:
$ 1.23万 - 项目类别:
TESTOSTERONE AND GROWTH HORMONE IMPROVE BODY COMPOSITION AND
睾酮和生长激素改善身体成分
- 批准号:
7954033 - 财政年份:2009
- 资助金额:
$ 1.23万 - 项目类别:
INVESTIGATOR INITIATED STUDY OF THE EFFECTS OF ANDROGEN THERAPY ON CARBOHYDRA
研究人员开始研究雄激素治疗对碳水化合物的影响
- 批准号:
7982111 - 财政年份:2008
- 资助金额:
$ 1.23万 - 项目类别:
A PHASE II/III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF URIDINE
尿苷 II/III 期、随机、双盲、安慰剂对照试验
- 批准号:
7982124 - 财政年份:2008
- 资助金额:
$ 1.23万 - 项目类别:
HORMONAL REGULATORS OF MUSCLE AND METABOLISM IN AGING (HORMA)--1 R01 AG18169-01
衰老过程中肌肉和新陈代谢的激素调节剂 (HORMA)--1 R01 AG18169-01
- 批准号:
7716680 - 财政年份:2008
- 资助金额:
$ 1.23万 - 项目类别:
相似国自然基金
Fosl1通过调控CD4+T淋巴细胞分化参与脓毒症性肺损伤的机制研究
- 批准号:81901948
- 批准年份:2019
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Role of CD8 T cell-mediated Pathology in Globoid Cell Leukodystrophy
CD8 T 细胞介导的病理学在球状细胞脑白质营养不良中的作用
- 批准号:
10634808 - 财政年份:2023
- 资助金额:
$ 1.23万 - 项目类别:
Role of apoE in HDL-mediated enhanced survival of human regulatory T-cells
apoE 在 HDL 介导的人类调节性 T 细胞存活增强中的作用
- 批准号:
10577476 - 财政年份:2023
- 资助金额:
$ 1.23万 - 项目类别:
Development of a Novel, Targeted Small Molecule Inhibitor of the Nucleoside Salvage Pathway to Treat Crohn's disease
开发一种新型核苷挽救途径靶向小分子抑制剂来治疗克罗恩病
- 批准号:
10820782 - 财政年份:2023
- 资助金额:
$ 1.23万 - 项目类别:
Harnessing Age-Associated B cells for a Universal Influenza Vaccine for the Aged
利用与年龄相关的 B 细胞开发针对老年人的通用流感疫苗
- 批准号:
10573680 - 财政年份:2022
- 资助金额:
$ 1.23万 - 项目类别:
Can Senolytics Improve the Aged Response to Viral Infection
Senolytics 能否改善老年人对病毒感染的反应
- 批准号:
10303445 - 财政年份:2021
- 资助金额:
$ 1.23万 - 项目类别: